Moderna’s Omicron Booster Strategy Lifts Biotechnology ETFs

Moderna (NasdaqGS: MRNA) jumped on Monday after announcing that a higher dosage booster of its vaccine could help mitigate COVID-19 Omicron risks before a tailor-made shot is finalized, lifting biotechnology sector-related exchange traded funds. On Monday, the Invesco Nasdaq Biotechnology ETF...